Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does aging impact advil's effectiveness in women?How does lipitor dosage affect liver enzyme levels?What's the minimum lipitor dose for results?What's the impact of salt substitutes with lipitor use?How does lurbinectedin's side effect profile differ from other cancer drugs?
See the DrugPatentWatch profile for vascepa
Common Side Effects of Vascepa Vascepa, also known as icosapent ethyl [1], is an omega-3 fatty acid medication primarily used to lower triglyceride levels and reduce the risk of cardiovascular events in patients with high triglycerides [2]. Like any medication, it can cause adverse reactions. Here are some of the most commonly reported side effects of Vascepa use. Gastrointestinal Issues Many patients taking Vascepa experience gastrointestinal problems, such as: * Nausea (23% of patients) [3] * Diarrhea (20%) [3] * Abdominal pain (14%) [3] * Constipation (8% to 10%) [3, 4] Other Side Effects Other commonly reported side effects of Vascepa include: * Allergic reactions (e.g., rash, itching, hives) (5% to 10%) [3, 4] * Increased liver enzymes (3% to 5%) [2] * Blood clotting issues (e.g., increased INR) (2% to 5%) [2] Serious Adverse Reactions While rare, serious adverse reactions to Vascepa can occur, including: * Hypersensitivity reactions (e.g., anaphylaxis) [5] * Acute pancreatitis [6] What to Do About Adverse Reactions If you experience any side effects while taking Vascepa, it's essential to inform your doctor. They can help manage symptoms, adjust your dosage, or switch you to a different medication if necessary. Precautions and Contraindications Certain patients should exercise caution when taking Vascepa, including those with: * Biliary disease or gallstones * History of pancreatitis * High risk of bleeding * Allergies to omega-3 fatty acids References: [1] Vascepa (icosapent ethyl) - DrugPatentWatch.com (${link to DrugPatentWatch.com}) [2] REDUCE-IT: Icosapent Ethyl Capsules for Cardiovascular Risk Reduction - FDA Approval [3] ClinicalTrials.gov: REDUCE-IT - Study to Test the Effectiveness of Vascepa (Icosapent Ethyl) on Cardiovascular Disease Events [4] Vascepa (icosapent ethyl) - ClinicalPharmacology.net [5] Vascepa (icosapent ethyl) - FDA Safety Labeling Changes [6] Vascepa (icosapent ethyl) - FDA Safety Alerts
Other Questions About Vascepa :